Label Changes for:
Relistor (methylnaltrexone bromide) Subcutaneous injection
Changes have been made to the ADVERSE REACTIONS and PATIENT PACKAGE INSERT sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – November 2009
What are the possible side effects of Relistor?